Management of acute HVE infection in a patient treated with rituximab for rheumatoid arthritis - 24/09/16
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 2 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Introduction |
Acute E hepatitis becomes more frequent in immunocompromised patients. No guidelines are available to date for the management of this infection and of the immunosuppressive treatment.
Methods |
We report a case of acute E hepatitis treated with ribavirine in a patient known for rheumatoid arthritis and treated with rituximab.
Case |
A 51-year-old woman known for rheumatoid arthritis and treated with rituximab was hospitalized for a jaundice secondary to an acute E hepatitis. She was treated with ribavirin 800mg twice a day during 2 months with a good efficacy and tolerance. Finally, 3 months after the acute E hepatitis, she benefited from 2 new 1000mg rituximab infusions because of the rheumatoid arthritis activity. The treatment was well tolerated without acute hepatitis. The follow-up of the HVE infection was realized with HVE PCR in the blood and 8 months after the last infusions, there were no chronic courses or acute hepatitis recurrence.
Conclusion |
This case highlights the safety and the efficacy of the reintroduction of rituximab after 2 months of treatment with ribavirin and a negative PCR.
Le texte complet de cet article est disponible en PDF.Keywords : Acute hepatitis E, Rituximab, Rheumatoid arthritis
Plan
Vol 83 - N° 5
P. 577-578 - octobre 2016 Retour au numéro
Article précédent
- Efficacy of zoledronic acid in Erdheim-Chester disease: A case report
- Lucile Poiroux, Frédéric Paycha, Marc Polivka, Hang-Korng Ea
- Tabetic arthropathy of the knee: MRI aspects
- Issam En-nafaa, Tarik Ziadi, Taoufik Africha
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?